Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toshimitsu Hamasaki

Showing results (1-10 of 203) with videos related to

Pageof 21
Sort By:
Journal of Biopharmaceutical Statistics|November 27, 2002
Practical issues and observations on the use of foreign clinical data in drug developmentMasashi Goto, Toshimitsu Hamasaki
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 21, 2022
[What Is an Estimand?-The Most Important Clinical Question in Oncology Trials]Toshimitsu Hamasaki, Frank Bretz
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 21, 2022
[Multiple Endpoints in Oncology Clinical Trials]Toshimitsu Hamasaki, Frank Bretz
Pharmaceutical Statistics|August 26, 2010
Practical issues and lessons learned from multi-regional clinical trials via case examples: a Japanese perspectiveYuki Ando, Toshimitsu Hamasaki
Journal of the National Cancer Institute|September 26, 2022
Weighing evidence: robustness vs quantityScott R Evans, Toshimitsu Hamasaki
Journal of Biopharmaceutical Statistics|April 26, 2011
Sample size determination in superiority clinical trials with multiple co-primary correlated endpointsTakashi Sozu, Tomoyuki Sugimoto, Toshimitsu Hamasaki
Statistics in Medicine|August 6, 2010
Sample size determination in clinical trials with multiple co-primary binary endpointsTakashi Sozu, Tomoyuki Sugimoto, Toshimitsu Hamasaki
International Journal of Dermatology|March 5, 2013
Sleep quality in patients with alopecia areata: questionnaire-based studyShigeki Inui, Toshimitsu Hamasaki, Satoshi Itami
Biometrical Journal. Biometrische Zeitschrift|July 10, 2013
Authors' replyTakashi Sozu, Tomoyuki Sugimoto, Toshimitsu Hamasaki
Biometrical Journal. Biometrische Zeitschrift|April 12, 2013
Partition testing in confirmatory adaptive designs with structured objectivesToshifumi Sugitani, Toshimitsu Hamasaki, Chikuma Hamada
Pageof 21

Showing results (1-10 of 203) with videos related to

Sort By:
Pageof 21
Journal of Biopharmaceutical Statistics|November 27, 2002
Practical issues and observations on the use of foreign clinical data in drug developmentMasashi Goto, Toshimitsu Hamasaki
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 21, 2022
[What Is an Estimand?-The Most Important Clinical Question in Oncology Trials]Toshimitsu Hamasaki, Frank Bretz
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 21, 2022
[Multiple Endpoints in Oncology Clinical Trials]Toshimitsu Hamasaki, Frank Bretz
Pharmaceutical Statistics|August 26, 2010
Practical issues and lessons learned from multi-regional clinical trials via case examples: a Japanese perspectiveYuki Ando, Toshimitsu Hamasaki
Journal of the National Cancer Institute|September 26, 2022
Weighing evidence: robustness vs quantityScott R Evans, Toshimitsu Hamasaki
Journal of Biopharmaceutical Statistics|April 26, 2011
Sample size determination in superiority clinical trials with multiple co-primary correlated endpointsTakashi Sozu, Tomoyuki Sugimoto, Toshimitsu Hamasaki
Statistics in Medicine|August 6, 2010
Sample size determination in clinical trials with multiple co-primary binary endpointsTakashi Sozu, Tomoyuki Sugimoto, Toshimitsu Hamasaki
International Journal of Dermatology|March 5, 2013
Sleep quality in patients with alopecia areata: questionnaire-based studyShigeki Inui, Toshimitsu Hamasaki, Satoshi Itami
Biometrical Journal. Biometrische Zeitschrift|July 10, 2013
Authors' replyTakashi Sozu, Tomoyuki Sugimoto, Toshimitsu Hamasaki
Biometrical Journal. Biometrische Zeitschrift|April 12, 2013
Partition testing in confirmatory adaptive designs with structured objectivesToshifumi Sugitani, Toshimitsu Hamasaki, Chikuma Hamada
Pageof 21